Hide filtersShow filters × Close Strategic advisory Fusion Health Bryan, Garnier & Co acts as Global Coordinator and Bookrunner of a Follow-on Offering of €30m for Erytech Pharma Bryan, Garnier & Co acts as Joint Lead Manager and Joint Bookrunner of DBV $133m IPO on NASDAQ. Bryan, Garnier & Co acts as Co-manager of LDR 97m$ follow-on offering on NASDAQ. Bryan, Garnier & Co leads the placement of the shares of Mauna Kea Technologies held by Creadev Bryan, Garnier & Co advises Locatel in its merger with Hoist Technology Bryan, Garnier & Co acts as Joint Manager and Bookrunner on Genomic Vision €26.4 m Euronext IPO, 4.7x oversubscribed Bryan, Garnier & Co successfully leads the €65.5 M Capital Increase for Transgene Bryan, Garnier & Co advised UDG Healthcare on its USD144 million acquisition of the communications business of KnowledgePoint360 Bryan, Garnier & Co. successfully leads a Secondary Placement for Erytech Pharma Bryan, Garnier & Co Acts as Joint Lead Manager and Joint Bookrunner of LDR Holding $86M IPO on NASDAQ Bryan, Garnier & Co has advised SpineVision® on a $10 Million Private Placement
